Giovanni Erminio

Image‐defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy‐induced variation, and impact on surgical outcomes

Stefano Avanzini, Luca Pio, Giovanni Erminio et al. · Pediatric Blood & Cancer · 2017 · 107 citations

Medicine, Oncology, Surgery +11

Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN study

J. A. Kohler, H Rubie, Victoria Castel et al. · European Journal of Cancer · 2013 · 88 citations

Medicine, Oncology, Pediatrics +5

Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma

Chiara Brignole, Danilo Marimpietri, Daniela Di Paolo et al. · Cancer Research · 2010 · 75 citations

Life Sciences, Immunology, Oncology +14

Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study

Loredana Amoroso, Giovanni Erminio, Guy Makin et al. · Cancer Research and Treatment · 2017 · 63 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry

Francesca Bagnasco, Silvia Caruso, Anita Andreano et al. · European Journal of Cancer · 2019 · 51 citations · Full text

Medicine, Oncology, Pediatrics +17